Align Technology Inc. ($ALGN) Stock Forecast: Up 5.1% Today

What is Align Technology Inc.?

Align Technology (ALGN) is a leading global medical device company specializing in the design, manufacture, and sale of the Invisalign system for teeth straightening and iTero intraoral scanners for digital scanning. The company's growth is fueled by the rising demand for clear aligners and digital scanning technology in orthodontic and dental sectors.

Why is Align Technology Inc. going up?

ALGN stock is up 5.1% on Feb 6, 2026 18:38

• A higher price target of $220 set by Piper Sandler for Align Technology post a robust Q4 showing, with revenue reaching $1.048 billion and $3.29 EPS, has bolstered investor confidence, resulting in a positive trend in the stock.
• Record revenue achieved by the company in Q4 and fiscal 2025, attributed to a significant increase in Clear Aligner case volumes worldwide, signals its strong market position and growth prospects, further elevating investor optimism.
• Despite negative earnings forecasts, Align Technology's strong performance and favorable 2026 outlook demonstrate its adept navigation of challenges and effective capitalization on market opportunities, contributing to the upward momentum in the market.

ALGN Price Chart

ALGN Technical Analysis

ALGN News

Piper Sandler raises Align Technology stock price target to $220 on Q4 beat

Piper Sandler has increased its price target for Align Technology (NASDAQ:ALGN) to $220 from $200, maintaining an Overweight rating after the company surpassed Q4 earnings and revenue expectations. Align Technology reported strong performance with $1.048 billion in revenue and $3.29 EPS, driven by growth in aligner and scanner products. The revised target aligns with InvestingPro's fair value assessment, suggesting the stock might be undervalued, and the company's initial 2026 guidance appears reasonable, anticipating continued positive outcomes.

https://m.investing.com/news/analyst-ratings/piper-sandler-raises-align-technology-stock-price-target-to-220-on-q4-beat-93CH-4491072?ampMode=1

RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand

Resmed Inc. (RMD) reported strong second-quarter fiscal 2026 results, with adjusted EPS increasing 15.6% year over year to $2.81, beating the Zacks Consensus Estimate. Revenues also surpassed expectations, rising 11% to $1.42 billion, driven by growth in both Sleep and Breathing Health and Residential Care Software segments. The company demonstrated significant margin expansion, with adjusted gross margin up 340 basis points to 62.6% and adjusted operating margin expanding 263 basis points to 36.6%.

https://www.tradingview.com/news/zacks:0e22b5fb8094b:0-rmd-stock-up-following-q2-earnings-revenue-beat-margins-expand/

Align Technology (ALGN) Q4 EPS Beat Tests Bearish Earnings Narratives

Align Technology (ALGN) reported robust Q4 2025 results with US$1.0 billion in revenue and US$1.89 Basic EPS, prompting a re-evaluation of bearish narratives. While the company's TTM net profit margin is 10.2% and earnings are forecast to grow 15.7% annually, past five years saw a 21.6% decline, creating a mixed picture. Additionally, its 5% annual revenue growth lags the US market's 10.3% forecast, and its P/E ratio of 30.7x is slightly above peers, although a DCF fair value suggests potential undervaluation.

https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/align-technology-algn-q4-eps-beat-tests-bearish-earnings-nar

Earnings call transcript: Envista Holdings Q4 2025 beats expectations

Envista Holdings (NVST) reported strong Q4 2025 results, exceeding analyst expectations with an EPS of $0.38 and revenues of $751 million. The company's core sales grew by 10.8%, driven by new product introductions and increased clinical training. Envista provided a positive outlook for 2026, projecting core sales growth of 2-4% and adjusted EPS between $1.35 and $1.45, underpinned by a solid value creation plan and continued investment in R&D.

https://www.investing.com/news/transcripts/earnings-call-transcript-envista-holdings-q4-2025-beats-expectations-93CH-4489241

Align Technology Reports Record Revenue for Q4 and Fiscal 2025

Align Technology announced record revenues for the fourth quarter and full fiscal year 2025, reaching $1.05 billion and $4.0 billion respectively. The growth was primarily driven by a significant increase in Clear Aligner case volumes across global regions and both orthodontic and GP dentist channels. The company expressed cautious optimism for continued growth in 2026 despite the dynamic macroeconomic environment.

https://orthodonticproductsonline.com/industry-news/company-news/align-technology-q4-2025-financial-results-record-revenue/

Trending Today

Fastly Inc. ($FSLY) Stock Forecast: Up 5.9% Today

Huntington Ingalls Industries Inc. ($HII) Stock Forecast: Up 7.4% Today

Cardano ($ADA) Crypto Forecast: Up 8.5% Today

Corning Incorporated ($GLW) Stock Forecast: Up 8.6% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 6.6% Today

Bitcoin ($BTC) Crypto Forecast: Up 5.7% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Up 7.0% Today

Royal Caribbean Cruises Ltd. ($RCL) Stock Forecast: Up 5.4% Today

Citigroup Inc. ($C) Stock Forecast: Up 6.0% Today

DaVita Inc. ($DVA) Stock Forecast: Down 5.4% Today

Align Technology Inc. Price History

31.06.2025 - ALGN Stock was down 35.7%

• ALGN stock saw a notable bearish movement today.
• The company's second-quarter earnings and revenue fell below expectations, prompting a significant drop in its stock price.
• Sales of Clear Aligners declined, and margins were squeezed, raising concerns among investors.
• Align's subdued guidance for the third quarter fueled the prevailing pessimism about the stock, leading to a decline of over 34%.

31.06.2025 - ALGN Stock was down 29.9%

• The stock of Align Technology dropped as the company failed to meet second-quarter earnings projections and offered a weaker third-quarter outlook, disappointing investors.
• Disappointing Q2 earnings and revenue numbers that fell below expectations from analysts added to the negative sentiment surrounding the stock.
• Despite the potential for growth from Invisalign and iTero upgrades, the market reacted strongly to the company's recent financial performance, resulting in a sharp decrease in ALGN's stock price.
• Today's bearish movement in ALGN underscores the market's attentiveness to earnings reports and future guidance, stressing the significance of meeting or surpassing investor expectations to uphold positive stock performance.

06.01.2026 - ALGN Stock was up 5.1%

• A higher price target of $220 set by Piper Sandler for Align Technology post a robust Q4 showing, with revenue reaching $1.048 billion and $3.29 EPS, has bolstered investor confidence, resulting in a positive trend in the stock.
• Record revenue achieved by the company in Q4 and fiscal 2025, attributed to a significant increase in Clear Aligner case volumes worldwide, signals its strong market position and growth prospects, further elevating investor optimism.
• Despite negative earnings forecasts, Align Technology's strong performance and favorable 2026 outlook demonstrate its adept navigation of challenges and effective capitalization on market opportunities, contributing to the upward momentum in the market.

01.07.2025 - ALGN Stock was up 5.3%

• Despite recent challenges with missed earnings and revenue estimates, ALGN witnessed a notable positive movement in the market today.
• The surge in market sentiment could be linked to significant investors showing a strong positive outlook on Align Technology, evident from the rise in options trading activities.
• The stock's technical position, which was previously considered oversold, along with potential signals of a reversal in trends resulting from analysts upgrading earnings estimates, likely fueled the positive momentum.
• Investors seem to perceive the recent decline in ALGN stock price as an attractive buying opportunity, particularly following the substantial decrease post the Q2 earnings miss, revenue shortfall, and margin tightening.

03.11.2025 - ALGN Stock was up 5.1%

• ALGN experienced a strong bullish movement today, driven by several positive developments:
• The launch of new aligner options and direct fabrication technology is expected to drive growth and margin gains for the company.
• Expansion into new markets like South Africa and the Philippines with innovative digital dentistry solutions is enhancing ALGN's global presence.
• The company's focus on digital innovation, patient engagement, and personalized treatment journeys is resonating well with practitioners and patients alike.
• Despite a recent share price jump and positive news flow, there is still a debate about the stock's valuation, with some suggesting it may be undervalued due to expanding clinical indications and increased adoption by dentists.

21.04.2025 - ALGN Stock was down 5.1%

• The downward movement in ALGN stock today may be linked to investors taking profits after a period of significant growth subsequent to obtaining NMPA approval in China.
• Despite highlighting long-term potential, short-term market factors and investor sentiment could be contributing to the decline in ALGN stock today.
• Investor evaluations of ALGN are likely being reconsidered post the recent regulatory approval, resulting in a temporary decrease in stock value.
• Market participants may be realigning their portfolios based on short-term factors, leading to fluctuations in ALGN's stock price despite positive long-term outlooks.

05.01.2026 - ALGN Stock was up 10.2%

• The company reported better-than-expected Q4 2025 earnings and revenue, with record revenues and clear aligner volumes, leading to a significant surge in its stock price.
• Despite the company's gross and operating margins contracting due to increased costs and expenses, investors were still impressed by the overall performance and outlook for 2026 revenue growth.
• The positive outlook for the company, driven by strategic priorities like international expansion and increased orthodontic utilization, contributed to the bullish sentiment surrounding ALGN stock.
• The market's enthusiastic response to the earnings report and optimistic projections reflects investors' confidence in the company's growth potential and ability to navigate the dynamic macro environment.

13.07.2025 - ALGN Stock was up 5.8%

• Despite a less optimistic growth forecast, the CEO's confidence in ALGN's undervalued shares could have positively influenced investor sentiment.
• The rise in ALGN's stock price may indicate investor confidence in the company's future potential and the CEO's belief in its undervaluation.
• This upward movement could imply that investors are looking beyond immediate hurdles, focusing on the company's innovation and market dominance in the long term.

03.01.2026 - ALGN Stock was down 5.2%

• The stock of Align Technology (ALGN) recently saw a significant decrease, potentially influenced by various factors:
• Historical patterns of missing revenue estimates in previous quarters may have caused investor uncertainty and selling pressure, despite the current expectations of revenue growth and earnings per share.
• A partnership with the University of Bern for a notable epidemiological study on oral health trends in Switzerland, though enhancing the company's reputation, may not have yielded immediate benefits to bolster investor confidence.
• Efforts to support healthcare research and initiatives, although laudable, might not have directly translated into immediate financial gains, contributing to a negative investor outlook.
• General market conditions and sector-specific influences could have also affected ALGN stock's decline, as overall market trends can impact individual stock performance.

23.06.2025 - ALGN Stock was up 5.5%

• A comparison between ALGN and SAUHY might have highlighted ALGN as the better value stock option, attracting more investors to the company.
• Positive evaluations of ALGN's innovative products like Invisalign clear aligners and iTero intraoral scanners could have contributed to the bullish movement.
• Increased investor confidence in ALGN's future growth prospects and financial performance may have driven the stock's upward momentum today.

30.09.2025 - ALGN Stock was up 10.1%

• ALGN experienced a significant increase in its stock price today following the release of its Q3 earnings, which exceeded both earnings and revenue projections.
• The earnings surpassed expectations by +10.13% and revenue by +2.49%, highlighting the company's robust financial performance and strong market demand for its products.
• Investor sentiment appears positive regarding ALGN's future growth potential, driven by its innovative dental solutions and leading position in clear aligner technology.
• The outperformance in financial results suggests that ALGN is effectively leveraging the growing interest in orthodontic treatments, establishing a favorable position for its stock in the market.

30.09.2025 - ALGN Stock was up 5.4%

• ALGN stock notably surged in today's trading.
• The remarkable Q3 earnings and revenue exceeded expectations by a substantial margin, bolstering market confidence.
• However, despite the positive financial results, investors may have been unsettled by the considerable decrease in margins, potentially affecting the stock's performance.
• Investors are keenly observing upcoming developments to evaluate Align Technology's ability to sustain its growth momentum while addressing margin concerns.